TY - JOUR
T1 - Decreased renal clearance of xanthine and hypoxanthine in a patient with renal hypouricemia
T2 - A new defect in renal handling of purines
AU - Kawachi, M.
AU - Kono, N.
AU - Kiyokawa, H.
AU - Mineo, I.
AU - Nakajima, H.
AU - Shimizu, T.
AU - Yorifuji, S.
AU - Kuwajima, M.
AU - Tarui, S.
PY - 1992
Y1 - 1992
N2 - Renal handling of urate, xanthine and hypoxanthine was studied in a hypouricemic patient who had increased plasma concentrations of xanthine and hypoxanthine. The patient, a 50-year-old man, had been suffering from Parkinson's disease, while neither systemic disorders nor particular renal diseases known to affect plasma purine levels were found. His serum urate level was 58 ± 6 μmol/l (healthy controls for males, 310 ± 48 μmol/l, mean ± SD) and the renal uric acid clearance was 3 times higher than that of the controls, establishing a diagnosis of renal hypouricemia. Xanthine and hypoxanthine concentrations in the plasma were elevated to 1.3 ± 0.1 μmol/l (controls, 0.5 ± 0.3) and 5.9 ± 3.5 μmol/l (controls, 1.6 ± 0.4), respectively. Both renal xanthine and hypoxanthine clearance was only half the value of the controls, indicating reduced urinary excretion of xanthine, and hypoxanthine appears to be responsible for their elevation in plasma. A probenecid loading test revealed no response of urinary urate excretion but normal responses of xanthine and hypoxanthine excretion. However, urinary excretion of urate, xanthine or hypoxanthine did not respond at all to pyrazinamide administration. These findings indicate that the patient had a defective renal handling of xanthine and hypoxanthine as well as urate.
AB - Renal handling of urate, xanthine and hypoxanthine was studied in a hypouricemic patient who had increased plasma concentrations of xanthine and hypoxanthine. The patient, a 50-year-old man, had been suffering from Parkinson's disease, while neither systemic disorders nor particular renal diseases known to affect plasma purine levels were found. His serum urate level was 58 ± 6 μmol/l (healthy controls for males, 310 ± 48 μmol/l, mean ± SD) and the renal uric acid clearance was 3 times higher than that of the controls, establishing a diagnosis of renal hypouricemia. Xanthine and hypoxanthine concentrations in the plasma were elevated to 1.3 ± 0.1 μmol/l (controls, 0.5 ± 0.3) and 5.9 ± 3.5 μmol/l (controls, 1.6 ± 0.4), respectively. Both renal xanthine and hypoxanthine clearance was only half the value of the controls, indicating reduced urinary excretion of xanthine, and hypoxanthine appears to be responsible for their elevation in plasma. A probenecid loading test revealed no response of urinary urate excretion but normal responses of xanthine and hypoxanthine excretion. However, urinary excretion of urate, xanthine or hypoxanthine did not respond at all to pyrazinamide administration. These findings indicate that the patient had a defective renal handling of xanthine and hypoxanthine as well as urate.
KW - Hypoxanthine
KW - Renal hypouricemia
KW - Uric acid
KW - Xanthine
UR - http://www.scopus.com/inward/record.url?scp=0026703542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026703542&partnerID=8YFLogxK
U2 - 10.1159/000186961
DO - 10.1159/000186961
M3 - Article
C2 - 1501740
AN - SCOPUS:0026703542
SN - 0028-2766
VL - 61
SP - 428
EP - 431
JO - Nephron
JF - Nephron
IS - 4
ER -